Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3542247
Max Phase: Preclinical
Molecular Formula: C27H47N5O5
Molecular Weight: 521.70
Molecule Type: Small molecule
Associated Items:
ID: ALA3542247
Max Phase: Preclinical
Molecular Formula: C27H47N5O5
Molecular Weight: 521.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@H](CC1CCC1)[C@@H](O)C(N)=O)C2(C)C)C(C)(C)C
Standard InChI: InChI=1S/C27H47N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-20,33H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16+,17-,18-,19+,20+/m0/s1
Standard InChI Key: FEBWCINGHXXUCV-GNVSMLMZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 521.70 | Molecular Weight (Monoisotopic): 521.3577 | AlogP: 1.50 | #Rotatable Bonds: 8 |
Polar Surface Area: 153.86 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: | CX LogP: 0.86 | CX LogD: 0.86 |
Aromatic Rings: 0 | Heavy Atoms: 37 | QED Weighted: 0.33 | Np Likeness Score: 0.32 |
1. Ghosal A, Yuan Y, Tong W, Su AD, Gu C, Chowdhury SK, Kishnani NS, Alton KB.. (2011) Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor., 39 (3): [PMID:21123164] [10.1124/dmd.110.036996] |
Source(1):